StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cytokinetics's pe ratio was 702.5× on Jul 31, 2017, against 6.5× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Jul 31, 2017702.5×+698.0
2011Jan 31, 20114.5×−0.5
2010Dec 31, 20105.0×–

More Cytokinetics figures

See a number that looks wrong?